141 related articles for article (PubMed ID: 22264176)
1. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer.
Molina CA; Sarabia-Estrada R; Gokaslan ZL; Witham TF; Bydon A; Wolinsky JP; Sciubba DM
J Neurosurg Spine; 2012 Apr; 16(4):365-72. PubMed ID: 22264176
[TBL] [Abstract][Full Text] [Related]
2. Fractionated, single-port radiotherapy delays paresis in a metastatic spinal tumor model in rats.
Bagley CA; Bookland MJ; Pindrik JA; Ozmen T; Gokaslan ZL; Wolinsky JP; Witham TF
J Neurosurg Spine; 2007 Sep; 7(3):323-7. PubMed ID: 17877267
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis.
Gok B; McGirt MJ; Sciubba DM; Garces-Ambrossi G; Nelson C; Noggle J; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL
Neurosurgery; 2009 Jul; 65(1):193-9; discussion 199-200. PubMed ID: 19574842
[TBL] [Abstract][Full Text] [Related]
4. Intraosseous delivery of paclitaxel-loaded hydroxyapatitealginate composite beads delaying paralysis caused by metastatic spine cancer in rats.
Abe T; Sakane M; Ikoma T; Kobayashi M; Nakamura S; Ochiai N
J Neurosurg Spine; 2008 Nov; 9(5):502-10. PubMed ID: 18976182
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human bone morphogenetic protein-2-induced ossification of the ligamentum flavum in rats and the associated global modification of histone H3.
Hou XF; Fan DW; Sun CG; Chen ZQ
J Neurosurg Spine; 2014 Sep; 21(3):334-41. PubMed ID: 24949905
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of oncogel delays paresis in rat metastatic spinal tumor model.
Bagley CA; Bookland MJ; Pindrik JA; Ozmen T; Gokaslan ZL; Witham TF
J Neurosurg Spine; 2007 Aug; 7(2):194-8. PubMed ID: 17688059
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the effects of recombinant human bone morphogenetic protein-2 on pain-associated behaviors in a rat model following implantation near the sciatic nerve.
Zanella JM; Waleh N; Orduña J; Montenegro J; Paulin J; McKay WF; Wilsey J
J Neurosurg Spine; 2016 Aug; 25(2):154-64. PubMed ID: 26989976
[TBL] [Abstract][Full Text] [Related]
8. Axonal loss in murine peripheral nerves following exposure to recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge.
Margolis DS; Wu EW; Truchan LM
J Bone Joint Surg Am; 2013 Apr; 95(7):611-9. PubMed ID: 23553296
[TBL] [Abstract][Full Text] [Related]
9. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
10. Effect of hyperglycemia on progressive paraparesis in a rat etastatic spinal tumor model.
McGirt MJ; Gok B; Shepherd S; Noggle J; Garcés Ambrossi GL; Bydon A; Gokaslan ZL
J Neurosurg Spine; 2009 Jan; 10(1):9-15. PubMed ID: 19119926
[TBL] [Abstract][Full Text] [Related]
11. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
[TBL] [Abstract][Full Text] [Related]
12. A rat model of metastatic spinal cord compression using human prostate adenocarcinoma: histopathological and functional analysis.
Sarabia-Estrada R; Zadnik PL; Molina CA; Jimenez-Estrada I; Groves ML; Gokaslan ZL; Bydon A; Witham TF; Wolinsky JP; Sciubba DM
Spine J; 2013 Nov; 13(11):1597-606. PubMed ID: 23810458
[TBL] [Abstract][Full Text] [Related]
13. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
[TBL] [Abstract][Full Text] [Related]
14. A novel rat model for the study of intraosseous metastatic spine cancer.
Mantha A; Legnani FG; Bagley CA; Gallia GL; Garonzik I; Pradilla G; Amundson E; Tyler BM; Brem H; Gokaslan ZL
J Neurosurg Spine; 2005 Mar; 2(3):303-7. PubMed ID: 15796355
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
[TBL] [Abstract][Full Text] [Related]
16. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
17. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
[TBL] [Abstract][Full Text] [Related]
18. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
[TBL] [Abstract][Full Text] [Related]
19. Instrumented Lumbar Corpectomy and Spinal Reconstruction Comparing rhBMP-2/Compression-Resistant Matrix, rhBMP-2/Absorbable Collagen Sponge/Ceramic Granules Mixture, and Autograft in Two Different Devices: A Study in Sheep.
Toth JM; Schwartz DG; Mobasser JP; Williams J
Spine (Phila Pa 1976); 2016 Mar; 41(6):E313-22. PubMed ID: 26536446
[TBL] [Abstract][Full Text] [Related]
20. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion.
Cottrill E; Pennington Z; Wolf MT; Dirckx N; Ehresman J; Perdomo-Pantoja A; Rajkovic C; Lin J; Maestas DR; Mageau A; Lambrechts D; Stewart V; Sciubba DM; Theodore N; Elisseeff JH; Witham T
J Neurosurg Spine; 2023 Jul; 39(1):113-121. PubMed ID: 37021767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
